Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleEZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway.AuthorsDing, Nan; You, Abin; Zhao, Senxia; Yang, Hu; Lai, Chunping; Ye, FengPublicationMedical Oncology, 2023, Vol 40, Issue 10, p1ISSN1357-0560Publication typeArticleDOI10.1007/s12032-023-02147-x